Academician Alexander Ginsburg announced that the Russian vaccine against all types of cancer successfully passed tests conducted on laboratory mice.
Speaking to Gazeta news on the sidelines of the Petersburg International Economic Forum, the academic indicated that the vaccine has passed tests on mice, and it is expected that this vaccine will be given to cancer patients by injection directly into the malignant tumor or will be injected intramuscularly according to the patient’s condition.
The academic explained that the vaccine was manufactured based on mRNA technology
He says: “The most important advantage of this technology is that it allows the creation of very large concentrations of the target antigen in the cells, that is, the protein or peptides that the innovator encoded in the mRNA. This is necessary for the infected person’s immune system to be able to distinguish between a healthy cell and a malignant one.”
He adds: “We have proven that it is necessary to either inject the vaccine into the tumor or into the muscle. Because if it is given in the form of drops through the mouth, it will reach the liver because it is covered by a fatty envelope. But if it is injected into the tumor or muscle, it will be distributed evenly throughout the body".
Ginsburg points out that the vaccine was tested on mice with melanoma, and researchers noticed that 15 days after vaccination, that is, when the immune system begins to work, there was a significant difference in the size of the tumor between vaccinated and unvaccinated animals. The result was that the unvaccinated mice died between days 19 and 22, while the vaccinated mice are still alive.
A successful discovery!
ReplyDelete